During 2023 the ALA will continue to formulate a series of Consensus Practice Statements for diagnosis and management of key lymphoma subtypes. These will be developed in collaboration with the ALLG, with consultation requested from HSANZ.
Please find information on complete statements below:
More information to come so watch this space!
If you are interested in participating in or supporting the development of the practice statements please contact the ALA Executive Administrator.